Thor Medical ASA (OSL:TRMED)

Thor Medical ASA Cash Flow Statement

Financials in millions NOK. Fiscal year is January - December.

Fiscal Year	FY 2024	FY 2023	FY 2022
Period Ending	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022
Net Income	-42.21	-26.56	-
Depreciation & Amortization	2.38	0.33	-
Stock-Based Compensation	2.81	2.1	-3.3
Other Operating Activities	-2.03	17.03	-5.46
Change in Accounts Payable	13.13	-	-
Change in Other Net Operating Assets	1.95	-32.4	-97.98
Operating Cash Flow	-23.98	-64.09	-409.08
Capital Expenditures	-0.14	-	-5.63
Cash Acquisitions	-	4.26	-
Other Investing Activities	1.7	2.02	3.16
Investing Cash Flow	1.56	6.28	-2.46
Long-Term Debt Repaid	-0.48	-0.16	-5.52
Net Debt Issued (Repaid)	-0.48	-0.16	-5.52
Issuance of Common Stock	114.35	0.15	250.81
Other Financing Activities	-9.82	-0.32	-17.16
Financing Cash Flow	104.04	-0.33	228.13
Foreign Exchange Rate Adjustments	-	1.2	4.43
Miscellaneous Cash Flow Adjustments	-0	0	-
Net Cash Flow	81.62	-56.95	-178.99
Free Cash Flow	-24.12	-64.09	-414.71
Free Cash Flow Per Share	-0.10	-0.37	-3.60
Cash Interest Paid	0.1	-	0.07
Cash Income Tax Paid	-	0.76	1.1
Levered Free Cash Flow	-6.49	-34.91	-
Unlevered Free Cash Flow	-6.42	-34.91	-
Change in Net Working Capital	-15.07	32.87	-

Updated Aug 30, 2024. Source: S&P Global Market Intelligence. Standard template. Financial Sources.